Recalibrating the risks and benefits of lithium therapy [EDITORIALS]
Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.
Source: The British Journal of Psychiatry - Category: Psychiatry Authors: Berk, M., Cowdery, S., Williams, L., Malhi, G. S. Tags: EDITORIALS Source Type: research
More News: Bipolar | Cancer | Cancer & Oncology | Dementia | Lithium | Mania | Psychiatry | UK Health